KPIs & Operating Metrics(New)
Advance Purchase Agreements (Apas)Breakdown Of AssetsCollabration Revenue By CategoryCollabration Revenue By Category AnnualCost Of SalesDeferred Revenue By SegmentDoses DeliveredEmployee StatisticsGrant Revenue By Category AnnualGrant Revenue By CategoyGross Margin %Gross ProfitIncome (Loss) Before Income Tax By RegionManufacturing Technology Center (Mtc)Operating Expense As A % Of Total Revenue %Operating Expense SegregationProduct Revenue By Geography %Product Revenue By Geography Annual %Product Sales By GeographyProduct Sales By Geography AnnualProfitabilityProfitability %Profitability AnnualProfitability Annual %Property And Equipment BreakdownProperty And Equipment By GeographyPurchase CommitmentsRemaining Performance ObligationRemaining Performance ObligationsRevenue By Major CustomersRevenue By Major Customers %Revenue By SegmentRevenue By Segment %Revenue By Segment AnnualRevenue By Segment Annual %Total Contractual Obligations AnnualTotal Deferred Revenue
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Moderna (MRNA) Gross Profit: 2016-2024

Historic Gross Profit for Moderna (MRNA) over the last 9 years, with Dec 2024 value amounting to $1.8 billion.

  • Moderna's Gross Profit fell 39.99% to $809.0 million in Q3 2025 from the same period last year, while for Sep 2025 it was $1.1 billion, marking a year-over-year decrease of 67.97%. This contributed to the annual value of $1.8 billion for FY2024, which is 17.77% down from last year.
  • Per Moderna's latest filing, its Gross Profit stood at $1.8 billion for FY2024, which was down 17.77% from $2.2 billion recorded in FY2023.
  • In the past 5 years, Moderna's Gross Profit registered a high of $15.9 billion during FY2021, and its lowest value of $795.0 million during FY2020.
  • Its 3-year average for Gross Profit is $5.9 billion, with a median of $2.2 billion in 2023.
  • Per our database at Business Quant, Moderna's Gross Profit surged by 1,894.21% in 2021 and then slumped by 84.44% in 2023.
  • Yearly analysis of 5 years shows Moderna's Gross Profit stood at $795.0 million in 2020, then spiked by 1,894.21% to $15.9 billion in 2021, then decreased by 12.66% to $13.8 billion in 2022, then plummeted by 84.44% to $2.2 billion in 2023, then declined by 17.77% to $1.8 billion in 2024.